# Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis

> **NCT02637310** · PHASE2 · COMPLETED · sponsor: **PharmaKing** · enrollment: 108 (actual)

## Conditions studied

- Acute Bronchitis

## Interventions

- **DRUG:** N02RS1 1200mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02637310
- **Lead sponsor:** PharmaKing
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2016-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02637310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02637310, "Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02637310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*